Outpatient management of chronic heart failure

Elisabeth Kaldara, Despina Sanoudou, Stamatis Adamopoulos, John N. Nanas

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: Heart failure (HF) treatment attracts a share of intensive research because of its poor HF prognosis. In the past decades, the prognosis of HF has improved considerably, mainly as a consequence of the progress that has been made in the pharmacological management of HF.

Areas covered: This article reviews the outpatient pharmacological management of chronic HF due to left ventricular systolic dysfunction and offers recommendations on the use of various drugs. In addition, the present article attempts to provide practical therapeutic algorithms based on current clinical strategies.

Expert opinion: Continued research directed toward identifying factors associated with high pharmacotherapy guideline adherence and understanding of variants that influence response to drugs will hopefully halt or reverse the major pathophysiological mechanisms involved in this syndrome.

Original languageEnglish
Pages (from-to)17-41
Number of pages25
JournalExpert Opinion on Pharmacotherapy
Volume16
Issue number1
DOIs
Publication statusPublished - 1 Jan 2015
Externally publishedYes

Fingerprint

Outpatients
Heart Failure
Pharmacology
Guideline Adherence
Expert Testimony
Left Ventricular Dysfunction
Research
Pharmaceutical Preparations
Drug Therapy
Therapeutics

Keywords

  • aldosterone antagonists
  • angiotensin-converting enzyme inhibitors
  • chronic heart failure
  • drug therapy
  • β-adrenergic blockers

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Kaldara, E., Sanoudou, D., Adamopoulos, S., & Nanas, J. N. (2015). Outpatient management of chronic heart failure. Expert Opinion on Pharmacotherapy, 16(1), 17-41. https://doi.org/10.1517/14656566.2015.978286

Outpatient management of chronic heart failure. / Kaldara, Elisabeth; Sanoudou, Despina; Adamopoulos, Stamatis; Nanas, John N.

In: Expert Opinion on Pharmacotherapy, Vol. 16, No. 1, 01.01.2015, p. 17-41.

Research output: Contribution to journalArticle

Kaldara, E, Sanoudou, D, Adamopoulos, S & Nanas, JN 2015, 'Outpatient management of chronic heart failure', Expert Opinion on Pharmacotherapy, vol. 16, no. 1, pp. 17-41. https://doi.org/10.1517/14656566.2015.978286
Kaldara, Elisabeth ; Sanoudou, Despina ; Adamopoulos, Stamatis ; Nanas, John N. / Outpatient management of chronic heart failure. In: Expert Opinion on Pharmacotherapy. 2015 ; Vol. 16, No. 1. pp. 17-41.
@article{bebedca25b9941ceb890a1002c23a3d3,
title = "Outpatient management of chronic heart failure",
abstract = "Introduction: Heart failure (HF) treatment attracts a share of intensive research because of its poor HF prognosis. In the past decades, the prognosis of HF has improved considerably, mainly as a consequence of the progress that has been made in the pharmacological management of HF.Areas covered: This article reviews the outpatient pharmacological management of chronic HF due to left ventricular systolic dysfunction and offers recommendations on the use of various drugs. In addition, the present article attempts to provide practical therapeutic algorithms based on current clinical strategies.Expert opinion: Continued research directed toward identifying factors associated with high pharmacotherapy guideline adherence and understanding of variants that influence response to drugs will hopefully halt or reverse the major pathophysiological mechanisms involved in this syndrome.",
keywords = "aldosterone antagonists, angiotensin-converting enzyme inhibitors, chronic heart failure, drug therapy, β-adrenergic blockers",
author = "Elisabeth Kaldara and Despina Sanoudou and Stamatis Adamopoulos and Nanas, {John N.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1517/14656566.2015.978286",
language = "English",
volume = "16",
pages = "17--41",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Outpatient management of chronic heart failure

AU - Kaldara, Elisabeth

AU - Sanoudou, Despina

AU - Adamopoulos, Stamatis

AU - Nanas, John N.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Introduction: Heart failure (HF) treatment attracts a share of intensive research because of its poor HF prognosis. In the past decades, the prognosis of HF has improved considerably, mainly as a consequence of the progress that has been made in the pharmacological management of HF.Areas covered: This article reviews the outpatient pharmacological management of chronic HF due to left ventricular systolic dysfunction and offers recommendations on the use of various drugs. In addition, the present article attempts to provide practical therapeutic algorithms based on current clinical strategies.Expert opinion: Continued research directed toward identifying factors associated with high pharmacotherapy guideline adherence and understanding of variants that influence response to drugs will hopefully halt or reverse the major pathophysiological mechanisms involved in this syndrome.

AB - Introduction: Heart failure (HF) treatment attracts a share of intensive research because of its poor HF prognosis. In the past decades, the prognosis of HF has improved considerably, mainly as a consequence of the progress that has been made in the pharmacological management of HF.Areas covered: This article reviews the outpatient pharmacological management of chronic HF due to left ventricular systolic dysfunction and offers recommendations on the use of various drugs. In addition, the present article attempts to provide practical therapeutic algorithms based on current clinical strategies.Expert opinion: Continued research directed toward identifying factors associated with high pharmacotherapy guideline adherence and understanding of variants that influence response to drugs will hopefully halt or reverse the major pathophysiological mechanisms involved in this syndrome.

KW - aldosterone antagonists

KW - angiotensin-converting enzyme inhibitors

KW - chronic heart failure

KW - drug therapy

KW - β-adrenergic blockers

UR - http://www.scopus.com/inward/record.url?scp=84917706614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84917706614&partnerID=8YFLogxK

U2 - 10.1517/14656566.2015.978286

DO - 10.1517/14656566.2015.978286

M3 - Article

VL - 16

SP - 17

EP - 41

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 1

ER -